Although the tumor-suppressor role of miR-181a in CML cells has been reported [17, 28–32], the effect of miR-181a on BCR-ABL-induced leukemogenesis has not been studied. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.